- Added to Email Alerts
Chronic Leukemia
Latest News View All
-
COVID Toes, Seasonal Chilblains Share Similar Immune Responses
-
AlertFDA Grants Zanubrutinib an Accelerated Approval in MZL -
AlertFDA Approval for Zanubrutinib in Waldenström’s Macroglobulinemia
-
Protein Profiles May Predict Stable, Progressive Chronic Lymphocytic Leukemia
-
Ibrutinib Tied to Worsening Blood Pressure, Hypertension
-
Convalescent Plasma Saves Lives in Blood Cancer and COVID-19
-
EHA 2021Zanubrutinib Better Than Ibrutinib in CLL/SLL?
-
Timing Important for COVID Vax in Patients With Blood Cancers
Perspective View All
Journal Articles View All
-
Autophagy in Hematological Malignancies
-
Pulmonary Pathology of COVID-19 Following Severe Disease
-
Cardio-Oncology: Ibrutinib Effect Reveals Insights Into AF
-
Combination Obinutuzumab, Ibrutinib, and Venetoclax in CLL
-
Acalabrutinib vs Idelalisib-R or Bendamustine-R in CLL
-
Cladribine With Concurrent or Delayed Rituximab in HCL
Additional Resources
Medscape Drugs & Diseases
- Chronic Lymphocytic Leukemia Treatment Protocols
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hairy Cell Leukemia
- Leukemias
Medscape Education